<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Energy metabolism in muscle
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Energy metabolism in muscle
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Energy metabolism in muscle
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Basil T Darras, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Marc C Patterson, MD, FRACP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John F Dashe, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 10, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with metabolic myopathies have underlying defects of energy production in muscle. Most affected patients have dynamic symptoms, such as exercise intolerance, muscle pain, and cramps upon exercise, rather than static symptoms, such as a fixed weakness of a specific muscle group.
        </p>
        <p>
         To better understand these disorders, this topic review provides an overview of energy metabolism in muscle. Clinical aspects of metabolic myopathies are presented separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6193.html" rel="external">
          "Approach to the metabolic myopathies"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6197.html" rel="external">
          "Metabolic myopathies caused by disorders of lipid and purine metabolism"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2941.html" rel="external">
          "Overview of inherited disorders of glucose and glycogen metabolism"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5151.html" rel="external">
          "Mitochondrial myopathies: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Prior to a review of the pathways of energy metabolism, it is helpful to first briefly review the sources of energy in muscle.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          ENERGY SUBSTRATES IN EXERCISING MUSCLE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The main types of "fuel" used by muscle for energy metabolism are glycogen, glucose, and free fatty acids [
         <a href="#rid1">
          1-3
         </a>
         ]. The particular energy sources used by working muscle for aerobic metabolism depend upon a number of factors including the intensity, type, and duration of exercise, physical conditioning, and diet [
         <a href="#rid4">
          4-6
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         At rest, muscle predominantly uses fatty acids [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         During high-intensity isometric exercise, anaerobic glycolysis and the creatine kinase reaction, in which phosphocreatine is converted to adenosine triphosphate (ATP), are the primary sources of energy [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         With submaximal exercise, the type of substrate used by muscle is heavily dependent upon the relative intensity of exercise. During low-intensity submaximal exercise, the main sources of energy are blood glucose and free fatty acids. With high-intensity submaximal exercise, the proportion of energy derived from glycogen and glucose is increased, and glycogen becomes the main source. Fatigue is experienced when glucose and glycogen stores are depleted (as when a marathon runner hits the "wall").
        </p>
        <p>
        </p>
        <p>
         Sources of muscle energy also vary with the duration of exercise. During the first hour of mild, low-intensity exercise (such as jogging), glucose, glycogen, and free fatty acids are the major sources of energy. The uptake of free fatty acids by muscle increases substantially during one to four hours of mild to moderate prolonged exercise; after four hours, lipid oxidation becomes the major source of energy  (
         <a class="graphic graphic_table graphicRef55245" href="/z/d/graphic/55245.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1433.html" rel="external">
          "Exercise physiology"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          ENERGY METABOLISM IN MUSCLE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Muscle contraction and relaxation depend primarily upon energy derived from hydrolysis of adenosine triphosphate (ATP). A number of biochemical processes in muscle fibers are responsible for maintaining a constant supply of ATP. These include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glycogen or glucose metabolism
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oxidative phosphorylation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Creatine kinase reaction by which phosphocreatine is converted to ATP
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Purine nucleotide cycle
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lipid metabolism
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Glycogen or glucose metabolism
         </span>
         <span class="headingEndMark">
          —
         </span>
         Energy generation via the metabolism of glycogen or glucose in muscle occurs either aerobically or anaerobically.
        </p>
        <p class="headingAnchor" id="H3599657033">
         <span class="h3">
          Aerobic glycolysis
         </span>
         <span class="headingEndMark">
          —
         </span>
         During dynamic forms of exercise (isotonic), such as walking or running, aerobic glycolysis appears to play an important role in energy production. With aerobic glycolysis, pyruvate is formed through the same steps described in anaerobic glycolysis (see
         <a class="local">
          'Anaerobic glycolysis'
         </a>
         below), but oxidative decarboxylation of pyruvate takes place through the pyruvate dehydrogenase complex, generating acetyl coenzyme A (CoA). CoA enters the tricarboxylic acid (TCA) cycle, also known as the citric acid cycle or Krebs cycle, where it is converted into carbon dioxide and water  (
         <a class="graphic graphic_figure graphicRef67253" href="/z/d/graphic/67253.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid8">
          8,9
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Anaerobic glycolysis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic glycolysis supplies energy in relatively rare circumstances. This pathway is primarily used during conditions of high-intensity, sustained, isometric muscular activity (eg, lifting heavy objects), particularly in the setting of limited blood flow and oxygen supply to exercising muscle fibers.
        </p>
        <p>
         Phosphorylase, phosphorylase b kinase, and the debranching enzymes are responsible for the production of glucose-1-phosphate from glycogen  (
         <a class="graphic graphic_figure graphicRef81164" href="/z/d/graphic/81164.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid10">
          10
         </a>
         ]. The rate-limiting step in glycolysis, however, is the conversion of fructose-6-phosphate to fructose-1,6-diphosphate by the enzyme phosphofructokinase (PFK). The last step in glycolysis is the conversion of pyruvate to lactate by lactate dehydrogenase.
        </p>
        <p>
         The development of fatigue is related to the increased concentration of lactate within muscle fibers; lactate is the fundamental marker of mismatch between cellular energy supply and demand. Other molecules suggested as biomarkers of fatigue include inorganic phosphate (Pi), adenosine diphosphate (ADP), urea, insulin-like growth factor 1, creatine kinase, and glutamine [
         <a href="#rid11">
          11-13
         </a>
         ]. As an example, maximal acute exercise to exhaustion is associated with a systemic pH as low as 6.80 and serum lactate concentrations as high as 20 to 25 meq/L [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Oxidative phosphorylation
         </span>
         <span class="headingEndMark">
          —
         </span>
         The oxidative phosphorylation system, localized in the inner mitochondrial membrane, is the main source of energy in muscle and other cells  (
         <a class="graphic graphic_figure graphicRef67253" href="/z/d/graphic/67253.html" rel="external">
          figure 1
         </a>
         ). Compared with glycolysis, this system produces 17 to 18 times as much ATP from the same amount of glucose.
        </p>
        <p>
         The respiratory chain is composed of four multi-subunit complexes (I, II, III, and IV) linked by the mobile electron carriers coenzyme Q and cytochrome c. The reduced forms of nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH
         <sub>
          2
         </sub>
         ) are formed from the citric acid cycle and the beta-oxidation of fatty acids in the mitochondrial matrix. The respiratory chain transfers electrons from NADH (via complex I) and from reduced flavoproteins (via complex II and electron transfer flavoprotein-coenzyme Q oxidoreductase [ETF-Qo]) to coenzyme Q, then complex III, cytochrome c, and, finally, complex IV.
        </p>
        <p>
         Coenzyme Q and cytochrome c are very important components of the respiratory chain, serving as electron shuttles between the complexes [
         <a href="#rid12">
          12
         </a>
         ]. At the same time, complexes I, III, and IV pump electrons across the inner mitochondrial membrane from the matrix to the intermembrane space, which generates a proton gradient. The influx of these electrons (protons) back into the mitochondrial matrix releases energy that is used in the phosphorylation of ADP to ATP by complex V (ATP synthetase), which is also embedded in the inner mitochondrial membrane [
         <a href="#rid15">
          15,16
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Phosphocreatine pathway
         </span>
         <span class="headingEndMark">
          —
         </span>
         During very high intensity exercise, rapid formation of ATP can be accomplished through the reaction of phosphocreatine with ADP, catalyzed by creatine kinase. Because the amount of phosphocreatine in muscle is small, the duration of this reaction is very brief. When oxygenation of muscle again becomes adequate, stores of phosphocreatine are replenished [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Purine nucleotide cycle
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intensely exercising muscle can generate ATP over a short period of time using the adenylate kinase reaction; this reaction catalyzes the conversion of two ADP molecules into one molecule of ATP and one molecule of adenosine monophosphate (AMP). The AMP may then be deaminated to inosine monophosphate (IMP) by myoadenylate deaminase, with concurrent production of ammonia  (
         <a class="graphic graphic_figure graphicRef58885" href="/z/d/graphic/58885.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid17">
          17,18
         </a>
         ]. Myoadenylate deaminase activity seems to be higher in type 2, fast muscle fibers.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Lipid metabolism
         </span>
         <span class="headingEndMark">
          —
         </span>
         The metabolism of lipids in muscle occurs via beta- and omega-oxidation of fatty acids. Impairments at any of the important regulatory steps of lipid metabolism can lead to a myopathy and, in some cases, involvement of other organs. (See
         <a class="medical medical_review" href="/z/d/html/6197.html" rel="external">
          "Metabolic myopathies caused by disorders of lipid and purine metabolism"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Beta-oxidation of fatty acids
         </span>
         <span class="headingEndMark">
          —
         </span>
         At rest, fatty acids are the major energy substrate for muscle. Long-chain fatty acids constitute a major source of energy for prolonged, low-intensity exercise, lasting for more than 40 to 50 minutes [
         <a href="#rid19">
          19
         </a>
         ]. Fatty acids are derived from circulating, very low-density lipoproteins in the bloodstream or from triglycerides stored in adipocytes.
        </p>
        <p>
         Once in the cytoplasm, short- and medium-chain fatty acids of less than 10 carbon atoms can cross both the outer and inner mitochondrial membranes; these compounds subsequently enter the mitochondrial matrix where they undergo beta-oxidation after activation into their CoA esters  (
         <a class="graphic graphic_figure graphicRef59178" href="/z/d/graphic/59178.html" rel="external">
          figure 4
         </a>
         ).
        </p>
        <p>
         However, the mitochondrial membrane is not permeable to long-chain fatty acids; a multi-step process is therefore required for these compounds to be used by mitochondria. In the muscle cytoplasm, long-chain fatty acids are first activated by long-chain acyl-CoA synthetase to their CoA thioesters. The CoA thioesters are subsequently linked with carnitine by the enzyme carnitine palmitoyltransferase I (CPT I), which is located on the inner side of the outer mitochondrial membrane. The acylcarnitine form of the long-chain fatty acid, palmitoylcarnitine, is then transferred across the inner mitochondrial membrane by carnitine:acylcarnitine translocase [
         <a href="#rid20">
          20
         </a>
         ]; once in the mitochondrial matrix, it is converted back to free acyl-CoA derivative and carnitine by CPT II, which is localized on the inner side of the inner mitochondrial membrane  (
         <a class="graphic graphic_figure graphicRef59178" href="/z/d/graphic/59178.html" rel="external">
          figure 4
         </a>
         ).
        </p>
        <p>
         Once carnitine is released, the long-chain acyl-CoA derivative enters the beta-oxidation pathway. With every complete cycle, a two-carbon fragment is cleaved and an acetyl-CoA molecule is released. The acetyl-CoA is then oxidized via the citric acid cycle for energy production in muscle, heart, and other tissues  (
         <a class="graphic graphic_figure graphicRef67253" href="/z/d/graphic/67253.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         However, 90 percent of the hepatic acetyl-CoA is converted into ketones, which are an important source of energy for all tissues, particularly the brain. During prolonged fasting, ketones provide an important source of energy in brain tissue because the blood-brain barrier is impermeable to long-chain fatty acids [
         <a href="#rid21">
          21
         </a>
         ]. The intramitochondrial beta-oxidation of fatty acids requires the existence of chain-length specific enzymes. The complete oxidation of fatty acids is mediated by at least 11 enzymes  (
         <a class="graphic graphic_table graphicRef55245" href="/z/d/graphic/55245.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid22">
          22,23
         </a>
         ].
        </p>
        <p>
         The peroxisomal fatty acid oxidation enzymes are genetically distinct from the mitochondrial enzymes [
         <a href="#rid19">
          19
         </a>
         ]. In mitochondria, the first step of beta-oxidation occurs via a flavin adenine dinucleotide (FAD)-containing enzyme coupled to oxidative phosphorylation that generates ATP. In peroxisomes, however, beta-oxidation occurs via a flavin-containing oxidase that generates H
         <sub>
          2
         </sub>
         O
         <sub>
          2
         </sub>
         and then, through peroxisomal catalase, H
         <sub>
          2
         </sub>
         O and O
         <sub>
          2
         </sub>
         [
         <a href="#rid24">
          24
         </a>
         ]. Therefore, some energy is wasted. In mitochondria, the next steps in beta-oxidation are managed by two separate enzymes, while in peroxisomes they are managed by a single multifunctional enzyme protein.
        </p>
        <p>
         It is believed that fatty acid oxidation in peroxisomes handles very-long-chain fatty acids (&gt;C22), because these accumulate, particularly in neural tissues, in genetically linked peroxisomal disorders such as Zellweger syndrome and adrenoleukodystrophy. (See
         <a class="medical medical_review" href="/z/d/html/6147.html" rel="external">
          "Peroxisomal disorders"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Omega-oxidation of fatty acids
         </span>
         <span class="headingEndMark">
          —
         </span>
         During prolonged fasting, as much as 20 percent of total cellular oxidation of fatty acids is accomplished in liver microsomes (endoplasmic reticulum) through omega-oxidation, thereby resulting in the formation of dicarboxylic acids (DCAs) [
         <a href="#rid25">
          25
         </a>
         ]. DCAs are further metabolized through beta-oxidation in peroxisomes and mitochondria.
        </p>
        <p>
         In metabolic defects of intramitochondrial fatty acid oxidation, mitochondrial beta-oxidation of DCAs is impaired at a time when the production of DCAs is increased due to the recruitment of microsomal omega-oxidation [
         <a href="#rid26">
          26
         </a>
         ], which explains the appearance of DCAs in the urine.
        </p>
        <p>
         However, DCAs are also produced in other settings, including normal fasting, diabetic ketoacidosis, and diets containing medium-chain triglycerides. In addition, thioesterases catalyze the deacylation of coenzyme A and the conjugation of the acyl groups to glycine and to carnitine [
         <a href="#rid27">
          27,28
         </a>
         ]. Thus, the detection of acylcarnitine derivatives in serum, and the detection of DCAs and acylglycines in urine, has proven valuable for the diagnosis of inborn errors of fatty acid oxidation [
         <a href="#rid29">
          29,30
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H400796899">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fuel sources
         </strong>
         – Muscle contraction and relaxation depend primarily upon energy derived from hydrolysis of adenosine triphosphate (ATP). The main types of fuel used by muscle to generate ATP are glycogen, glucose, and free fatty acids. The particular energy sources used by working muscle for aerobic metabolism depend upon a number of factors including the intensity, type, and duration of exercise, physical conditioning, and diet. (See
         <a class="local">
          'Energy substrates in exercising muscle'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Glycolysis
         </strong>
         – Energy generation via the metabolism of glycogen or glucose in muscle occurs either anaerobically or aerobically. (See
         <a class="local">
          'Glycogen or glucose metabolism'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Aerobic
         </strong>
         – During dynamic forms of exercise (isotonic), such as walking or running, aerobic glycolysis appears to play an important role in energy production. (See
         <a class="local">
          'Aerobic glycolysis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Anaerobic
         </strong>
         – Anaerobic glycolysis supplies energy in relatively rare circumstances. This pathway is primarily used during conditions of high-intensity, sustained, isometric muscular activity (eg, lifting heavy objects), particularly in the setting of limited blood flow and oxygen supply to exercising muscle fibers. (See
         <a class="local">
          'Anaerobic glycolysis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Oxidative phosphorylation
         </strong>
         – The oxidative phosphorylation system, localized in the inner mitochondrial membrane, is the main source of energy in muscle and other cells  (
         <a class="graphic graphic_figure graphicRef67253" href="/z/d/graphic/67253.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="local">
          'Oxidative phosphorylation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rapid production of ATP
         </strong>
         – During very high intensity exercise, rapid formation of ATP can be accomplished through the reaction of phosphocreatine with adenosine diphosphate (ADP) catalyzed by creatine kinase. In addition, intensely exercising muscle can generate ATP over a short period of time using the purine nucleotide cycle  (
         <a class="graphic graphic_figure graphicRef58885" href="/z/d/graphic/58885.html" rel="external">
          figure 3
         </a>
         ). (See
         <a class="local">
          'Phosphocreatine pathway'
         </a>
         above and
         <a class="local">
          'Purine nucleotide cycle'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lipid metabolism
         </strong>
         – The metabolism of lipids in muscle occurs via beta- and omega-oxidation of fatty acids.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Beta oxidation
         </strong>
         – Short- and medium-chain fatty acids of less than 10 carbon atoms can cross both the outer and inner mitochondrial membranes; these compounds subsequently enter the mitochondrial matrix where they undergo beta-oxidation after activation into their coenzyme A (CoA) esters  (
         <a class="graphic graphic_figure graphicRef59178" href="/z/d/graphic/59178.html" rel="external">
          figure 4
         </a>
         ). Long-chain fatty acids are a major source of energy for prolonged, low-intensity exercise, lasting for more than 40 to 50 minutes. However, the mitochondrial membrane is not permeable to long-chain fatty acids; a multi-step process is therefore required for these compounds to be used by mitochondria. (See
         <a class="local">
          'Lipid metabolism'
         </a>
         above and
         <a class="local">
          'Beta-oxidation of fatty acids'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Omega oxidation
         </strong>
         – During prolonged fasting, as much as 20 percent of total cellular oxidation of fatty acids is accomplished in liver microsomes through omega-oxidation, thereby resulting in the formation of dicarboxylic acids (DCAs). DCAs are further metabolized through peroxisomal and mitochondrial beta-oxidation. (See
         <a class="local">
          'Omega-oxidation of fatty acids'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Felig P, Wahren J. Fuel homeostasis in exercise. N Engl J Med 1975; 293:1078.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wahren J. Glucose turnover during exercise in man. Ann N Y Acad Sci 1977; 301:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Essén B. Intramuscular substrate utilization during prolonged exercise. Ann N Y Acad Sci 1977; 301:30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gollnick PD, Piehl K, Saltin B. Selective glycogen depletion pattern in human muscle fibres after exercise of varying intensity and at varying pedalling rates. J Physiol 1974; 241:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Essén B. Glycogen depletion of different fibre types in human skeletal muscle during intermittent and continuous exercise. Acta Physiol Scand 1978; 103:446.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Das AM, Steuerwald U, Illsinger S. Inborn errors of energy metabolism associated with myopathies. J Biomed Biotechnol 2010; 2010:340849.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lithell H, Orlander J, Schéle R, et al. Changes in lipoprotein-lipase activity and lipid stores in human skeletal muscle with prolonged heavy exercise. Acta Physiol Scand 1979; 107:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis SF, Haller RG. The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue. J Appl Physiol (1985) 1986; 61:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis SF, Vora S, Haller RG. Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency. J Appl Physiol (1985) 1991; 70:391.
          </a>
         </li>
         <li class="breakAll">
          DiMauro S, Tsujino S. Nonlysosomal glycogenoses. In: Myology, 3rd ed, Engel A, Franzini-Armstrong C (Eds), McGraw-Hill, New York 2004. p.1473-1533.
         </li>
         <li class="breakAll">
          Akman HO, Oldfors A, DiMauro S. Glycogen storage diseases of muscle. In: Neuromuscular Disorders of Infancy, Childhood and Adolescence: A Clinician's Approach, 2nd ed, Darras BT, Jones HR Jr, Ryan MM, De Vivo DC (Eds), Academic Press, San Diego 2015. p.735.
         </li>
         <li class="breakAll">
          Hirano M, Akman HO, DiMauro S. Metabolic and Mitochondrial Myopathies. In: Merritt's Neurology, 14th ed., Louis ED, Mayer SA, Noble JM (Eds), Wolters Kluwer, 2021. p.1011.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bestwick-Stevenson T, Toone R, Neupert E, et al. Assessment of Fatigue and Recovery in Sport: Narrative Review. Int J Sports Med 2022; 43:1151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindinger MI, Heigenhauser GJ, McKelvie RS, Jones NL. Blood ion regulation during repeated maximal exercise and recovery in humans. Am J Physiol 1992; 262:R126.
          </a>
         </li>
         <li class="breakAll">
          DiMauro S, De Vivo D. Diseases of carbohydrate, fatty acid, and mitochondrial metabolism. In: Basic neurochemistry: Molecular, cellular, and medical aspects, 7th ed, Seigel G, Albers RW, Brady S, Price D (Eds), Elsevier Academic Press, 2006. p.695.
         </li>
         <li class="breakAll">
          Taanman JW, Williams S. Structure and function of the mitochondrial oxidative phosphorylation system. In: Mitochondrial Disorders in Neurology 2, Schapira AHV, DiMauro S (Eds), Butterworth-Heinemann, Boston 2002. p.1.
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Adel BA, Tarnopolsky MA. Metabolic myopathies: update 2009. J Clin Neuromuscul Dis 2009; 10:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fishbein WN. Myoadenylate deaminase deficiency: inherited and acquired forms. Biochem Med 1985; 33:158.
          </a>
         </li>
         <li class="breakAll">
          Tein I. Lipid storage myopathies due to fatty acid oxidation defects. In: Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach, 2nd ed, Darras BT, Jones HR Jr, Ryan MM, De Vivo DC (Eds), Academic Press, Amsterdam 2015. p.761-786.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rubio-Gozalbo ME, Bakker JA, Waterham HR, Wanders RJ. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects. Mol Aspects Med 2004; 25:521.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tein I. Metabolic myopathies. Semin Pediatr Neurol 1996; 3:59.
          </a>
         </li>
         <li class="breakAll">
          Hashimoto T. Peroxisomal and mitochondrial enzymes. In: Progress in Clinical and Biological Research, Coates P, Tanaka K (Eds), Wiley, New York 1992. p.19.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luo MJ, He XY, Sprecher H, Schulz H. Purification and characterization of the trifunctional beta-oxidation complex from pig heart mitochondria. Arch Biochem Biophys 1993; 304:266.
          </a>
         </li>
         <li class="breakAll">
          Basic Neurochemistry: Molecular, Cellular and Medical Aspects, 7th, Brady S, Siegel G, Albers RW, Price DL (Eds), Elsevier Academic Press, Boston 2006.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Darras BT, Friedman NR. Metabolic myopathies: a clinical approach; part I. Pediatr Neurol 2000; 22:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krahling JB, Gee R, Murphy PA, et al. Comparison of fatty acid oxidation in mitochondria and peroxisomes from rat liver. Biochem Biophys Res Commun 1978; 82:136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kølvraa S, Gregersen N. Acyl-CoA:glycine N-acyltransferase: organelle localization and affinity toward straight- and branched-chained acyl-CoA esters in rat liver. Biochem Med Metab Biol 1986; 36:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roe CR, Millington DS, Maltby DA, et al. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency. Pediatr Res 1985; 19:459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baretz BH, Ramsdell HS, Tanaka K. Identification of n-hexanoylglycine in urines from two patients with Jamaican vomiting sickness. Clin Chim Acta 1976; 73:199.
          </a>
         </li>
         <li class="breakAll">
          Millington D. New methods for the analysis of acylcarnitines and acyl-coenzyme A compounds. In: Mass Spectrometry in Biomedical Research, Gaskell S (Ed), John Wiley, New York 1986. p.97.
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6212 Version 17.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1178025" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Fuel homeostasis in exercise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/270932" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Glucose turnover during exercise in man.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/270923" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Intramuscular substrate utilization during prolonged exercise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4278539" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Selective glycogen depletion pattern in human muscle fibres after exercise of varying intensity and at varying pedalling rates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/152564" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Glycogen depletion of different fibre types in human skeletal muscle during intermittent and continuous exercise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20589068" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Inborn errors of energy metabolism associated with myopathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/539455" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Changes in lipoprotein-lipase activity and lipid stores in human skeletal muscle with prolonged heavy exercise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3528113" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1826293" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1826293" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1826293" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1826293" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35468639" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Assessment of Fatigue and Recovery in Sport: Narrative Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1733331" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Blood ion regulation during repeated maximal exercise and recovery in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1733331" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Blood ion regulation during repeated maximal exercise and recovery in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1733331" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Blood ion regulation during repeated maximal exercise and recovery in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19258857" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Metabolic myopathies: update 2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4004819" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Myoadenylate deaminase deficiency: inherited and acquired forms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4004819" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Myoadenylate deaminase deficiency: inherited and acquired forms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15363639" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8795843" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Metabolic myopathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8795843" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Metabolic myopathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8323290" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Purification and characterization of the trifunctional beta-oxidation complex from pig heart mitochondria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8323290" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Purification and characterization of the trifunctional beta-oxidation complex from pig heart mitochondria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10738913" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Metabolic myopathies: a clinical approach; part I.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/666829" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Comparison of fatty acid oxidation in mitochondria and peroxisomes from rat liver.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3741707" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Acyl-CoA:glycine N-acyltransferase: organelle localization and affinity toward straight- and branched-chained acyl-CoA esters in rat liver.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4000772" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1000831" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Identification of n-hexanoylglycine in urines from two patients with Jamaican vomiting sickness.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
